论文部分内容阅读
目的:比较盐酸左氧氟沙星与氧氟沙星治疗盆腔炎患者的临床疗效及安全性。方法:选取2014年1月—2015年3月间收治的盆腔炎患者96例为研究对象,将其随机分为观察组与对照组,每组48例;观察组患者均给予盐酸左氧氟沙星治疗,对照组患者均给予氧氟沙星治疗,比较两组患者治疗后的临床疗效及安全性。结果:观察组患者治疗后的总有效率为93.75%高于对照组为77.08%(P<0.05),其不良反应的发生率为6.25%低于对照组为16.67%(P<0.05)。结论:在盆腔炎患者治疗中采用盐酸左氧氟沙星的临床疗效优于氧氟沙星的治疗,且安全性较高。
Objective: To compare the clinical efficacy and safety of levofloxacin hydrochloride and ofloxacin in the treatment of pelvic inflammatory disease. Methods: A total of 96 patients with pelvic inflammatory disease who were admitted to our hospital from January 2014 to March 2015 were enrolled in this study. They were randomly divided into observation group and control group, 48 cases in each group. Patients in observation group were treated with levofloxacin hydrochloride. All patients were treated with ofloxacin, the clinical efficacy and safety of the two groups were compared. Results: The total effective rate of the observation group after treatment was 93.75% higher than that of the control group (77.08%, P <0.05). The incidence of adverse reactions was 6.25% in the observation group and 16.67% (P <0.05) lower than that in the control group. Conclusion: Levofloxacin hydrochloride is superior to ofloxacin in the treatment of patients with pelvic inflammatory disease, and its safety is higher.